PERSPECTA

News from every angle

Back to headlines

Novo Nordisk Reports Positive Trial Results for Childhood Obesity Drug

Novo Nordisk announced positive Phase 3 trial data showing that semaglutide significantly reduced obesity rates among young children. Approximately 40 percent of participants achieved a healthy BMI range when combining the treatment with lifestyle modifications.

7 Sept, 10:00 — 7 Sept, 11:06
PostShare

The Story

Analyzing sources…

Source Diversity

Source Diversity

High (54/100)
6 sources33/33
Spectrum spread2/5 buckets covered8/33
Far L
Left
Center4
Center (4)
investing-comReutersmorningstartaiwan-news
Right2
Right (2)
seeking-alphawsj
Far R
Geographic diversity3 regions13/34
US4Intl1Taiwan1